Skip to main content

Advertisement

Table 3 Treatment of sinus aspergilloma and impact on TNFα antagonist therapy

From: Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy

Case Systemic antifungal treatment Surgical treatment Impact on TNFα antagonist therapy
1 -- Aspergilloma removal after meatotomy in January 2005 Temporary discontinuation
2 -- May 2007 Treatment stopped before surgery
3 -- August 2005, September 2006 Temporary discontinuation
4 -- Aspergilloma removal by endoscopy in June 2007 Treatment stopped before surgery
5 -- Aspergilloma removal after meatotomy in January 2005 TNFα antagonist therapy considered contraindicated because of the aspergilloma
6 -- Aspergilloma removal after meatotomy in August 2006, December 2006, September 2007 TNFα antagonist therapy delayed for 18 months